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ABSTRACT
The increased emergence of multi-drug and pandrug resistant bacteria necessitates the identification of new therapies. Although
antibiotics are used to treat infections, the novel antibiotic discovery rate lags behind development of resistance. Antibiotics in clinical use
combat infection through bactericidal or bacteriostatic action, which allows for selection of resistant strains. To impede or avoid resistance,
treatments targeting microbial cell pathways critical for virulence and pathogenicity, but not essential for viability are being explored. One
such signaling pathway is quorum sensing (QS) which regulates virulence factor expression in many pathogenic bacteria. Interference
with this signaling pathway results in attenuation of pathogenicity and allows the host immune response system to eradicate the infection.
Natural products have long been a rich source of antibiotic scaffolds as well as inhibitors of QS. Panax ginseng has been used as an herbal
panacea for thousands of years, yet its ability to inhibit bacterial growth and QS is only beginning to be characterized. This review
provides a brief outline of the microbial infection process, an overview of quorum sensing, an introduction to the use of natural products
as alternative therapies, and a synopsis of the current literature describing the anti-bacterial and anti-QS activities of Panax ginseng.
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_____________________________________________________________________________________________________________
INTRODUCTION
The continuous use and abuse of antibiotics selects for
resistant strains of bacteria. Consequently, the problem of
antibiotic resistance has been growing at an alarming rate in
recent years. Of the 2 million patients that acquire nosocomial infections, it was estimated 90,000 will die as a
result and more than 70% will be infected by multi-drug
resistant bacteria requiring more than one antibiotic for
treatment (National Institutes of Health, NIAID 2006). Thus,
there is an urgent need for novel antibiotics.
The rate of finding new antibiotics has slowed by 56%
in the past 20 years as evidenced by the number of drugs
approved by the FDA (Fischbach and Walsh 2009). Inefficient screening and the great cost and time required to
Received: 25 September, 2010. Accepted: 26 July, 2011.

bring a new antibiotic to market are part of the reason for
this decreasing trend in the development of novel antibiotics. To effectively eradicate infections, either novel antimicrobials or alternative therapies are needed. These can be
synthesized in the laboratory, derived from natural products,
or a combination of both. The study of ethnobotany has led
to the identification of many botanical sources with antimicrobial activity at a rate greater than random screening
(Khafagi and Dewedar 2000). The focus of this review is
the potential therapeutic use of extracts and compounds
from Panax ginseng, which has been used since ancient
times as a “cure-all.” P. ginseng has been shown to affect
Gram positive and Gram negative bacteria growth and
pathogenicity both directly and indirectly as detailed in this
review. Brief summaries of the infection process and quoInvited Review
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Fig. 1 Pseudomonas aeruginosa infection. (A) Pseudomonas aeruginosa structures and factors important for virulence (B) Pseudomonas aeruginosa
infection process: bypass of host primary defense, adhesion, colonization and host effects.

elastase (Bever and Iglewski 1988), LasA staphylolytic protease (Goldberg and Ohman 1987; Toder et al. 1991), phospholipase C (Liu 1966), pyocyanin (Stewart-Tull and Armstrong 1972), pyoverdin (Ankenbauer et al. 1985), rhamnolipids (Burger et al. 1962; Edwards and Hayashi 1965),
exotoxin A (Liu 1973; Liu and Hsieh 1973; Liu et al. 1973),
lipopolysaccharide (LPS) (Homma and Suzuki 1961; Homma et al. 1963) and exoenzymes S and U (Iglewski et al.
1978; Finck-Barbancon et al. 1997). These enable multiple
stages of the infection process including host tissue damage,
cellular necrosis, and pro-inflammatory immune response.
Many of these virulence factors must be secreted by
Pseudomonas aeruginosa to exert their action on the host.
To secrete the extracellular products, P. aeruginosa makes
use of six different secretion systems (Ma et al. 2003; Saier
2006). All of these affect virulence by facilitating transport
of the aforementioned virulence factors (Wretlind and Pavlovskis 1984; Lindgren and Wretlind 1987; Yahr et al. 1996;
Yahr et al. 1997; Duong et al. 2001; Ochsner et al. 2002;
Mougous et al. 2006; Hood et al. 2010).
Biofilm formation also plays a pivotal role in colonization (Costerton et al. 1999; Drenkard 2003). This occurs
when dense aggregates of cells adhere to surfaces and
become embedded in a matrix consisting of extracellular
DNA, proteins and polysaccharides such as alginate, Pel
(pellicle formation) and Psl (polysaccharide synthesis
locus) (Evans and Linker 1973; Friedman and Kolter 2004a,
2004b). Biofilm formation is associated with increased antibiotic resistance as well as chronic P. aeruginosa infections
(Nickel et al. 1985a, 1985b; Nichols et al. 1989; Drenkard
2003).
Thus the P. aeruginosa infection process, like that of all
pathogenic bacteria, is multilayered and complex. Underlying virtually every step of this process, adherence, colonization, virulence factor production, secretion and biofilm
formation, is the ability of the bacteria to communicate with
members of its own species and others to coordinate the
infection process and improve the chance of success. This is
accomplished through a signaling pathway called quorum
sensing (QS).

rum sensing (QS) are provided as background to fully appreciate the effects of ginseng on microbial pathogenesis.
AN OVERVIEW OF THE INFECTION PROCESS
Bacteria, are relatively simple in structure, yet have evolved
complex metabolisms which allow them to inhabit diverse
environments, one of which is the human body. Although
many are commensal or avirulent, invasion of primarily sterile sites in the body by opportunistic and pathogenic bacteria may cause disease. For this to occur, bacteria must
enter the host, adhere and colonize the site, acquire nourishment, and evade host defenses. Different bacteria use
methods unique to their species to invade tissues and disseminate through the body while dealing with local and
systemic inflammatory responses. For the purpose of this
review, which focuses on the ability of P. ginseng to inhibit
bacterial growth and virulence, only the infection process
for Pseudomonas aeruginosa, a common ubiquitous, opportunistic pathogen, will be detailed.
Individuals most often infected by P. aeruginosa are
burn victims (Tredget et al. 2004), those receiving mechanical ventilation (Garau and Gomez 2003; Cao et al. 2004),
immunocompromised individuals, including those with
AIDS or neutropenia (Obritsch et al. 2005), and those afflicted with compromised lung function, such as individuals
with diffuse panbronchiolitis (Homma et al. 1983) or cystic
fibrosis (CF) (Phair et al. 1970; Mearns et al. 1972; Hoiby
1974; Frederiksen et al. 1999). P. aeruginosa has become
quite successful in establishing infection due to its intrinsic
antibiotic resistance, low outer membrane permeability, presence of multidrug efflux pumps, hypermutability and ability to form biofilms. Fifty percent of hospitalized patients
are colonized by P. aeruginosa (Pollack 2000). Initial infection is acute, however, in chronic infections, as in the case
of individuals with CF, P. aeruginosa infection results in
host lung damage and eventual mortality (Hoiby et al.
1977).
P. aeruginosa that initially infect the host are planktonic,
motile cells that produce and secrete numerous toxins and
virulence factors necessary for establishing and maintaining
an infection (Fig. 1). After successfully passing the host’s
primary line of defense, the next step in the infection process is adhesion via binding to any of several different glycoproteins (Fig. 1). P. aeruginosa accomplishes this by producing virulence factors that help compromise the host
defenses, including the AprA alkaline protease (Duong et al.
1992), protease IV/PrpL (Wilderman et al. 2001), LasB

OVERVIEW OF QUORUM SENSING
QS is a type of communication process bacteria use to coordinate and synchronize their behavior (Nealson and Hastings 1979; Fuqua et al. 1996). In QS, bacteria synthesize
and secrete chemical signals that alter the transcriptional
program in a cell density dependent manner (Nealson et al.
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negative bacteria, including P. aeruginosa, is the LuxI/
LuxR system. The LuxI/R QS system was first identified in
V. fischeri as a regulator of bioluminescence through activation of the luciferase luxICDABEG operon (Eberhard et
al. 1981; Engebrecht et al. 1983; Engebrecht and Silverman
1984, 1987; Swartzman et al. 1990). The “I” and “R” proteins are at the heart of this type of QS, encoding the quoromone synthase and cytoplasmic receptor/transcriptional
activator, respectively. The quoromone involved in the
LuxI/R QS system is an HSL (Fig. 2C). HSLs contain a
homoserine lactone (HSL) ring and an acyl side chain
(Eberhard et al. 1981; Engebrecht and Silverman 1984,
1987). The side chain varies between four and 18 carbons in
length and may contain a modification, primarily at the C3
position depending upon the species (Table 1). The LuxI
protein synthesizes the HSL by transfer of a fatty acid chain
from an acylated carrier protein to S-adenosyl methionine
creating HSL and 5'-methylthioadenosine (Schaefer et al.
1996). The HSL is transported into and out of the cell by
diffusion (Kaplan and Greenberg 1985).
As the population density increases, the intracellular
concentration of HSL increases due to diffusion into the cell.
Inside the cell, HSL binds the LuxR protein (Urbanowski et
al. 2004). The stable ligand-bound LuxR binds and activates gene expression (Urbanowski et al. 2004).
QS signaling is so vital to the bacteria that often they
have more than one LuxI/R system or utilize the LuxI/R
system with other QS systems (Waters and Bassler 2005).
For example, P. aeruginosa, utilizes two LuxI/R based systems, the Las and the Rhl systems, and also synthesizes 2heptyl-3-hydroxy-4(1H)-quinolone (Pseudomonas quinolone signal or PQS), which is part of an additional regulatory circuit of the Las and Rhl pathways (reviewed in
Williams and Camara (2009)).

Fig. 2 Communication pathways affecting microbial virulence and
structures of the most well characterized quoromones. (A) Summary
of communication types; (B) Structures of AIP-I – IV (from left to right);
(C) HSL structure. The R group can vary as indicated in Table 1. (D)
Structures AI-2 from Salmonella (left) and Vibrio (right). (E) Structure of
the quinolonoes HHQ and PQS. (F) Generic structure of CAI-I. R may be
a hydroxyl group (CAI-1) or an amino group (Amino-CAI-1). (G) Structures of norepinephrine (left) and epinephrine (right). (B-F) adapted from
(Ng and Bassler 2009).

Gram positive bacteria intraspecies
communication
In Gram positive bacteria, the chemical signal is often a
modified oligopeptide (Solomon et al. 1996) or autoinducing peptide (AIP) as is the case for Staphylococcus
aureus (Ji et al. 1995) (Fig. 2B). Transport of these across
the membrane usually requires special transporters and peptide modifications such as processing and/or cyclization.
Extracellular accumulation of these signaling oligopeptides
results in activation of a two-component signaling system
which results in altered gene expression (reviewed in
Novick and Geisinger (2008)).

1970). Although first discovered in the bioluminescent bacteria Vibrio fischeri (Kempner and Hanson 1968; Nealson et
al. 1970; Eberhard 1972), QS systems have been identified
in many bacteria and, in addition to bioluminescence, affect
various cellular processes including conjugation, sporulation, biofilm formation, virulence factor production and secretion (Table 1).
The QS signals are also called autoinducers or quoromones. Specifically, quoromones identified in Gram positive bacteria include linear, modified, and cyclic peptides
and -butyrolactones, and 4,5-dihydroxy-2,3-pentandione
(DPD) derivatives (autoinducer 2 (AI-2)) (Havarstein et al.
1995; Ji et al. 1995; Solomon et al. 1996; Surette and
Bassler 1998; Surette et al. 1999; Miller et al. 2004). Gram
negative bacteria have been shown to use N-acylhomoserine
lactones (HSLs), 2-alkyl-4-quinolones, fatty acid methyl
esters, long-chain fatty acid derivatives, peptides, -butyrolactones, furanones, AI-2 and autoinducer 3 (AI-3) as indicators of population density. These signals may serve to
communicate with members of the same species, (intraspecies), different species (interspecies), different genera (intergenera) or between the bacteria and the host (interkingdom)
(Fig. 2A). A comprehensive review of QS is beyond the
scope of this review, thus only one or two examples of each
will be discussed.

Interspecies communication – the LuxS-based
system
The LuxS system is a form of interspecies communication;
it is widespread and both Gram negative and Gram positive
bacteria synthesize and respond to this class of quoromone;
termed AI-2 (reviewed in Ng and Bassler (2009)). This
phenomenon was first observed in the marine bacteria Vibrio harveyi (Greenberg et al. 1979).
V. harveyi synthesizes and recognizes three types of
quoromones (Henke and Bassler 2004). One is an intraspecies communication molecule; the N-(3-hydroxybutanoyl)
HSL (3OHC4-HSL) (Cao and Meighen 1989; Bassler et al.
1993). A second has been proposed to be an intergenera signal, CAI-1, which has not yet been purified from V. harveyi,
but was identified as (S)-3-hydroxytridecan-4-one in Vibrio
cholerae (Higgins et al. 2007) (Fig. 2F). The third is the
interspecies signal AI-2 (Surette et al. 1999; Schauder et al.
2001; Chen et al. 2002) (Fig. 2D).
AI-2 is used by both Gram negative and positive bacteria, and is often referred to as a universal signal. Even
bacteria, such as P. aeruginosa, that do not synthesize AI-2,
can detect AI-2 in the environment and alter gene expression accordingly, further emphasizing its role as a universal
signal (Duan et al. 2003; Duan and Surette 2007; Rezzonico
and Duffy 2008). Synthesis of AI-2 begins with LuxS con-

Gram negative bacteria intraspecies
communication
The major paradigm of intraspecies QS system in Gram
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Table 1 Gram negative bacteria with QS regulated virulence.
Bacteria
Gene
Autoinducer molecule
(AI)*
Aeromonas hydrophila
ahyI/ahyR
C4-HSL
Aeromonas salmonicida
Agrobacterium tumefaciens

asaI/asaR
traI/traR

C4-HSL and C6-HSL
3OC8-HSL and C6-HSL

Brucella melitensis
Burkholderia cenocepacia

vbjR
cepI/R

C12-HSL
C6-HSL and C8-HSL

HHQ

Burkholderia mallei

Burkholderia pseudomallei

bcam
0581

BDSF

bmaI1/R1
bmaI3/R3

C8-HSL and 3OC8-HSL
C8-HSL, OC8-HSL and C10HSL

bmaR4
bmaR5
pmlI1/R1
bpmI2/R2
bpmI3/R3

Burkholderia vietnamiensis
G4

bpmR4
bpmR5
hhqA/E

HHQ

cepI/R

C6-HSL and C8-HSL

bviI/R

C6-HSL, C8-HSL, C10-HSL,
C12-HSL and 3OC10-HSL
C6-HSL

Chromo-bacterium violaceum cviI/cviR
Erwinia carotovora subsp.
betavasculorum
Erwinia carotovora subsp.
carotovora 71
Erwinia carotovora subsp.
carotovora GS101
Erwinia carotovora subsp.
carotovora SCC3193
Klebsiella pneumoniae
Pantoea agglomerans pv.
‘gypsophilae’
Pantoea stewartii subsp.
Stewartii (formerly Erwinia
stewartii)
Pseudomonas aeruginosa

Pseudomonas aureofaciens
30-84

C8-HSL, C10-HSL, and
3OHC8-HSL
C8-HSL, C10-HSL, and
3OHC8-HSL
C8-HSL, C10-HSL, and
3OHC8-HSL

Virulence Factor

Reference

Type VI secretion system, biofilm
and metalloprotease production
Virulence factors
Ti plasmid conjugation

Khajanchi et al. 2009

Virulence factor
Virulence factor
Virulence factor, MprA protease
production and colonization
Virulence factor and colonization

Ulrich et al. 2004b
Ulrich et al. 2004b
Ulrich et al. 2004a; Valade et al.
2004
Ulrich et al. 2004a

Colony morphology, elastase
production

Diggle et al. 2006b

Rasch et al. 2007
Zhang et al. 1993
Hwang et al. 1994
Virulence factor production
Weeks et al. 2010
Virulence factor, protease,
Lewenza et al. 1999; Sokol et al.
chitinase, siderophore, biofilm and 2000; Huber et al. 2001; Lewenza
AidA production and swarming
and Sokol 2001; Aguilar et al.
motility
2003
Colony morphology and elastase
Diggle et al. 2006a
production
Virulence factor, motility, biofilm Boon et al. 2008; Deng et al.
formation, metalloprotease, lipase, 2009; Ryan et al. 2009
lipase chaperone and siderophore
expression, and Candida albicans
morphology
Virulence factor
Ulrich et al. 2004b
Virulence factor
Ulrich et al. 2004b

Lutter et al. 2001; Conway and
Greenberg 2002; Malott and Sokol
2007
Lutter et al. 2001; Malott and
Sokol 2007
McClean et al. 1997

ecbI/ecbR

3OC6-HSL

Biofilm formation and virulence
factors
Antibiotic and exoenzymes

hslI/hslR

3OC6-HSL

Exoenzymes

Chatterjee et al. 1995

carI/carR

3OC6-HSL

Carbapenems and
exoenzymes
Virulence factors and exoenzyme

Pirhonen et al. 1993; Swift et al.
1993
Pirhonen et al. 1993; Chatterjee et
al. 2005; Sjoblom et al. 2006
Balestrino et al. 2005
Chalupowicz et al. 2008

expI/expR1,expR2 3OC8-HSL and 3OC6-HSL

Costa and Loper 1997

pagI/pagR

AI-2
C6-HSL

Biofilm formation
Gall development

easI/esaR

3OC6-HSL

EPS and virulence factors

Beck von Bodman and Farrand
1995

lasI/lasR

3OC12-HSL

Alkaline protease, pyocyanin,
hydrogen cyanide, lectins, and
elastase

rhlI/rhlR

C4-HSL

Induces LasB and RhlI expression

qscR

3OC12-HSL

pqs
phzI/phzR

HHQ
C6-HSL

csaI/R

Unknown

Represses virulence factor
expression
Virulence factors
Virulence factors and biofilm
production
Colonization, exoprotease
production, and suppression of
mucoid phenotype

Gambello and Iglewski 1991;
Pearson et al. 1994; Brint and
Ohman 1995; Latifi et al. 1995;
Ochsner and Reiser 1995; Winson
et al. 1995
Brint and Ohman 1995; Latifi et
al. 1995; Ochsner and Reiser
1995; Pearson et al. 1997; Winzer
et al. 2000
Lequette et al. 2006
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Table 1 (Cont.)
Bacteria
Pseudomonas fluorescens
2P24
Pseudomonas fuscovaginae

Gene
pcoI/R

Autoinducer molecule (AI)*
3OC8-HSL

pfsI/R
pfvI/R
ppuI/R
ahlI/ahlR

C10-HSL and C12-HSL
3OC10-HSL and 3OC12-HSL
3OC6-HSL, 3OC8-HSL,
3OC10-HSL and 3OC12-HSL
C8-HSL

psyI/psyR

3OC6-HSL

solI/solR
phc

C6-HSL and C8-HSL
3-OH PAME

Rhodobacter sphaeroides

cerI/cerR

C14-HSL

Biofilm formation and virulence
factors
Unknown
Production of EPS and
exoenzyme synthesis
Phenazine antibiotic production

Serratia liquefaciens
Vibrio anguillarum

swrI/swrR
vanI/vanR

C4-HSL and C6-HSL
3OC12-HSL

Swarming motility
Unknown

vanM/vanN
vanS/vanQ

C6-HSL and
3OHC6-HSL
AI-2

luxP/luxQ

AI-2

Extracellular protease,
pigment and biofilm formation
Extracellular protease,
pigment and biofilm formation
Biofilm and virulence factor
production repression

cqsS/cqsA

CAI-1, amino-CAI-1

luxI/luxR
ainS/R
luxS/luxP, luxQ
luxM/luxN

3OC6-HSL
C8-HSL
AI-2
3OHC4-HSL

luxS/luxP, luxQ

AI-2

Vibrio parahaemo-lyticus

cqsA/cqsS
opaI/
opaR

CAI-1
Unknown

Vibrio salmonicida
Vibrio vulnificus
Xanthomonas campestris

luxI/luxR1, luxR2
luxS/luxP, luxQ
rpfC/rpfG

3OC6HSL
AI-2
11CH3C12-HSL

Yersinia pestis

yepI/yepR

Yersinia pseudo-tuberculosis

ypsI/ypsR
ytbI/ytbR

C8-HSL, 3OC6-HSL and C6HSL
C6-HSL, 3OC6HSL,
3OC7-HSL, C8-HSL, 3OHC8HSL, 3OC12-HSL

Pseudomonas putida
PCL1445
Pseudomonas syringae pv.
‘syringae’
Pseudomonas syringae pv.
‘tabaci’
Ralstonia solanacearum

Vibrio cholerae

Vibrio fischeri

Vibrio harveyi

Virulence Factor
Biofilm formation and wheat
rhizosphere colonization
Virulence factors
Virulence factors
Biofilm architecture
Antibiotic production

Reference
Wei and Zhang 2006
Mattiuzzo et al. 2011
Mattiuzzo et al. 2011
Dubern et al. 2006
Quinones et al. 2004; Quinones et
al. 2005
Shaw et al. 1997
Flavier et al. 1997
Brumbley et al. 1993; Flavier et
al. 1997
Puskas et al. 1997; Kirwan et al.
2006
Eberl et al. 1996
Milton et al. 1997; Croxatto et al.
2002
Milton et al. 2001
Croxatto et al. 2004
Miller et al. 2002

Miller et al. 2002; Higgins et al.
2007; Kelly et al. 2009
Bioluminescence
Eberhard et al. 1981
Gilson et al. 1995
Chen et al. 2002
Lilley and Bassler 2000; Mok et
Bioluminescence.
metalloprotease, siderophore, and al. 2003
exopolysaccharide production
Surette et al. 1999; Schauder et al.
2001; Chen et al. 2002
Henke and Bassler 2004
Haemolysin and protease
McCarter 1998; Henke and
production, opacity,
Bassler 2004
regulation of TTSS
Virulence factors
Nelson et al. 2007
Virulence factors
Kim et al. 2003
Virulence factors
Torres et al. 2007; He and Zhang
2008
Virulence factors
Atkinson et al. 1999; Gelhaus et
al. 2009
Aggregation and motility
Atkinson et al. 1999; Ortori et al.
2007

*Abbreviations used, AI-2, furanosyl borate diester; BDSF, cis-2-dodecenoic acid; CAI-1, Cholera autoinducer: HSL, homoserine lactone; C4-HSL, N-butanoyl-L-HSL;
3OHC4-HSL, N-3-hydroxybutanoyl-L-HSL; C6-HSL, N-hexanoyl-L-HSL; 3OC6-HSL, N-3-oxo-hexanoyl-HSL; 3OHC6-HSL, N-3-hydroxyhexanoyl-L-HSL; 3OC7-HSL, N3-oxo-septanoyl-L-HSL; C8-HSL, N-octanoyl-L-HSL; 3OHC8-HSL, N-3-hydroxy-octanonoyl-L-HSL; 3OC8-HSL, N-3-oxo-octanoyl-L-HSL; 3OC10-HSL, N-3-oxodecanoylL-HSL; 3OC12-HSL, N-3-oxododecanoyl-L-HSL; 11CH3C12-HSL, cis-11-methyl-2-dodecenoic acid; C14-HSL, 7,8-cis-N-tetradecenoyl-L-HSL; HHQ, 2-heptyl-3-hydroxy-4quinolone; 3-OH PAME, 3-OH-palmitic acid methyl ester

The microbial intestinal flora present in the healthy
human gut, produce another autoinducer termed autoinducer 3 (AI-3), which regulates the operons within the
locus for enterocyte effacement (LEE operons) and flagella
genes in enterohemorrhagic E. coli (Sperandio et al. 2003).
The LEE operons encode the proteins involved in Type 3
secretion systems and adhesion (Elliott et al. 1998). AI-3 is
detected by a two component system, QseBC, which also
recognizes norepinephrine and epinephrine (Fig. 2G) (Sperandio et al. 2003; Clarke et al. 2006; Kendall et al. 2007;
Reading et al. 2007). It has been proposed that this may be
a mechanism the bacteria use to sense that it is in the gut
(reviewed in Moreira and Sperandio (2010)). The synthesis
and chemical structure of AI-3 remains to be elucidated.
The detection pathway has been shown to be present in
numerous Gram negative bacteria; however, its role in commensal organisms needs further characterization.

verting ribose-homocysteine into homocysteine and DPD
(Schauder et al. 2001). Spontaneous rearrangement of DPD
results in the formation of different AI-2 compounds,
depending upon the environmental chemistry (Miller et al.
2004). One of the most well characterized pathways is that
of V. harveyi, which utilizes a furanosyl borate diester,
(2S,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran
borate (Fig. 2D, right panel) (Chen et al. 2002). Salmonella
enteric serovar Typhimurium and Escherichia coli use
(2R,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran (Fig.
2D, left panel) (Chen et al. 2002; Miller et al. 2004).
Interkingdom signaling
The infection process is complex and bacteria have evolved
to coordinate this process not only with members of their
own species and kingdom, but also with other kingdoms
capable of co-infecting the host and the host itself. This is
accomplished by signaling that feeds into the QS systems.
15
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Pseudomonas aeruginosa QS

was the appearance of resistant strains. Interestingly, penicillin resistance was central in Fleming’s seminal paper
(Fleming 1929).
Today, emerging antibiotic resistance in three groups of
pathogens is of particular public health concern: methicillin-resistant S. aureus (MRSA), multidrug resistant (MDR)
and extensively drug-resistant (XDR) Mycobacterium tuberculosis, and pandrug-resistant (PDR) and MDR Gram negative bacteria (Weigel et al. 2003; Falagas et al. 2005; Klevens et al. 2007). MRSA was first isolated in the United
States in 1968 (Barrett et al. 1968). It is estimated that invasive MRSA led to 18,650 in-hospital deaths in the US in
2005 (Klevens et al. 2007). MRSA is treated with vancomycin. Fortunately, only a handful of vancomycin resistant S.
aureus strains have been reported, nine in the US (Finks et
al. 2009). In 2008, there were an estimated 11.1 million
people with M. tuberculosis and 1.8 million M. tuberculosis-related deaths (World Health Organization 2010). It is
also estimated that 3.6% of all M. tuberculosis infections
are MDR and in some sections of the former Soviet Union,
as many as 28.3% of all new tuberculosis cases were with
MDR with 10% of these being XDR bacteria (World Health
Organization 2010). Recent reviews have addressed the
increased occurrence of MDR and PDR Gram negative
pathogens: Acinetobacter baumannii, Klebsiella pneumoniae, E. coli, and P. aeruginosa (Giske et al. 2008; Fischbach and Walsh 2009; Pfeifer et al. 2010). This increase not
only results in greater mortality rates, but also a heavier
economic burden (Giske et al. 2008). Unfortunately, the
development of novel antibiotics is not keeping pace with
the emergence of MDR and PDR Gram negative pathogens.
This is adding to the inherent resistance of these organisms.
For example, the rate of ceftazidime resistance for P. aeruginosa increased by 22% from 1997 to 2001 (Solomon et al.
2003). For especially pernicious infections caused by P.
aeruginosa, more than one antibiotic is needed for eradication.

The QS systems in P. aeruginosa are well characterized,
most likely because of their importance in virulence. P.
aeruginosa exhibits intraspecies, interspecies and interkingdom signaling. As described above, P. aeruginosa can respond to, but not synthesize AI-2 (Duan et al. 2003; Duan
and Surette 2007).
P. aeruginosa synthesizes and detects two HSLs, N-3oxo-dodecanoyl homoserine lactone (3OC12-HSL) and
butyryl homoserine lactone (C4-HSL) which bind LasR and
RhlR, respectively (reviewed in Fuqua et al. (1996)). These
complexes directly or indirectly regulate transcription of
more than 10% percent of the P. aeruginosa genome
(Schuster and Greenberg 2006). These two pathways in part
appear hierarchical, with the Las system upstream from the
Rhl system, although the Rhl pathway can be activated
during stationary phase in the absence of Las signaling
(Latifi et al. 1996; Pesci et al. 1997; Dekimpe and Déziel
2009).
A third receptor, QscR (quorum-sensing-control repressor), has also been identified in P. aeruginosa (Chugani et
al. 2001). QscR was initially shown to antagonize Las and
Rhl signaling and qscR mutants were hypervirulent (Chugani et al. 2001). Microarray studies show that the QscR
regulon is distinct, but partially overlaps that of LasR and
RhlR (Lequette et al. 2006). QscR has a relatively relaxed
specificity, leading to the suggestion that QscR may respond to HSLs produced by other bacteria present in a mixed
infection (Lequette et al. 2006; Oinuma and Greenberg
2011).
Recently, LasR-, RhlR-, and QscR-independent N-decanoyl-homoserine lactone (C10-HSL) signaling was observed
in P. aeruginosa (Chugani and Greenberg 2010). Receptorindependent, C10-HSL-dependent gene regulation requires
anthranilate produced by the kynurenine pathway (Chugani
and Greenberg 2010). Under the experimental conditions
used, the kynurenine pathway is the main source of anthranilate used for PQS synthesis (Farrow and Pesci 2007), the
signaling molecule used in the third QS pathway (Pesci et
al. 1999; McKnight et al. 2000), suggesting another layer of
control. Synthesis of PQS (Fig. 2E) is accomplished through
condensation reactions of anthranilate and -keto-(do)decanoate (Bredenbruch et al. 2005). The genes responsible,
pqsA, pqsB, pqsC, and pqsD, part of the pqsABCDE operon,
also synthesize over 50 2-alkyl-4-quinolones (Lepine et al.
2004; Bredenbruch et al. 2005). Many of these are in low
quantities and their physiological function is unknown
(Déziel et al. 2004). One of these, however, is the immediate precursor of PQS, 2-heptyl-4(1H)-quinolone (HHQ)
(Fig. 2E) (Déziel et al. 2004). The pqsABCDE operon is
conserved in Burkholderia pseudomallei, Burkholderia
thailandensis, and Burkholderia cenocepacia (Diggle et al.
2006b). These organisms synthesize HHQ, not PQS, and
thus, HHQ has been proposed to be an intergenera signaling
molecule. Expression of the pqsABCDE operon is also
regulated by interkingdom signaling, as it has been shown
to be activated by mammalian interferon-gamma (IFN-)
and dynorphin (Wu et al. 2005; Zaborina et al. 2007). PqsE
is important for host-pathogen adaptation (Rampioni et al.
2010).
The presence of many different QS systems serves as a
testament to the idea that QS serves an important role in
bacteria. By coordinating their behavior and only turning on
specific genes, such as those for virulence, at high cell density, the bacteria are able to achieve their goal successfully
and establish infection.

ALTERNATIVE THERAPIES
Alternative therapies are another avenue for treatment.
Since ancient times, people have used natural products to
treat infection. Antimicrobial activities have been identified
in plants from every continent including Antarctica (for
example: Romero et al. 2005; Ivanova et al. 2007; Oliveira
et al. 2007; McGaw et al. 2008; Goncalves et al. 2009;
Ahameethunisa and Hopper 2010). The antimicrobial properties of essential oils are also well established (Edris
2007; Alviano and Alviano 2009). Several classes of plant
compounds, including phenols, polyphenols, phenolic acid,
quinones, flavonoids, flavones, flavonols, tannins, coumarins, and polyacetylenes were found to be antimicrobial
(Toda et al. 1992; King and Tempesta 1994; Perrett et al.
1995; Fernandez et al. 1996; Avato et al. 1997; Peres et al.
1997).
Besides possessing antibacterial properties, herbal
remedies can also target QS. By targeting QS, an infective
property of the bacteria, one can potentially impede the rate
of resistance and infection. Halogenated furanones, synthesized by Delisea pulchra, were the first natural products
to exhibit anti-QS effect by competitively binding to LuxR
(Manefield et al. 1999, 2002). Evidence suggests that these
compounds may also inhibit AI-2 signaling (Ren et al.
2001). Six south Florida medicinal plants, Conocarpus
erectus, Bucida buceras, Callistemon viminalis, Quercus
virginiana, Tetrazygia bicolor and Chamaesyce hypericifolia, were shown to inhibit QS in Chromobacterium violaceum, Agrobacterium tumefaciens and P. aeruginosa (Adonizio et al. 2006, 2008a). Aqueous extracts from three of
these, C. erectus, B. buceras, and C. viminalis, significantly
reduced the levels of pyoverdin, LasA protease, LasB elastase and biofilm formation (Adonizio et al. 2008a). Use of
reporter constructs and HSL quantification suggested that C.
erectus and B. buceras extracts inhibited both 3OC12-HSL
and C4-HSL expression while C. viminalis extracts specific-

ANTIBIOTIC RESISTENCE
The discovery of penicillin by Alexander Fleming in the
1920’s heralded the golden age of antibiotics (Fleming
1929; Kong et al. 2010). At the time, many believed that the
discovery of these antibiotics would eradicate infectious
disease. Of course, concomitant with the use of antibiotics
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ally inhibited 3OC12-HSL expression (Adonizio et al.
2008a). Further testing of these three extracts in a Caenorhabditis elegans model system demonstrated that they inhibited P. aeruginosa gut infection death and toxin-dependent mortality in 60% and 50-90% of the worms, respectively, without host cytotoxic effects (Adonizio et al.
2008b).
Garlic extracts have also been shown to inhibit QS. In
DNA microarray experiments, addition of garlic extracts
down-regulated 92 QS-regulated P. aeruginosa genes (Rasmussen et al. 2005). The exact mechanism of anti-QS
action is unknown but believed to act upon either the I or R
protein since the mRNA levels of the key QS players were
unaffected (Rasmussen et al. 2005). Further experiments
demonstrated a synergistic effect of garlic and tobramycin
on P. aeruginosa biofilms in mice lungs (Bjarnsholt et al.
2005). Garlic altered the biofilm structure, increasing the
bacteria’s sensitivity to tobramycin, thus enhancing bacterial clearance from the lung (Bjarnsholt et al. 2005; Rasmussen et al. 2005). Garlic also has antibacterial effects
(Tessema et al. 2006). Moving from a mouse model to
human, a recent study was conducted analyzing the effect of
garlic in patients with cystic fibrosis (Smyth et al. 2010).
This is the first study conducted using an anti-QS agent in
humans. Levels of HSLs were used as a marker for anti-QS;
however, only 3OC12-HSL was detected. Overall, it was reported there was no significant difference between garlictreated patients and their placebo counterparts. This may be
attributed to small sample sizes (Smyth et al. 2010).
Other plants have been researched for their anti-infective properties based on their traditional use. One, P. ginseng, is the main focus of this review.

of ginseng yield different kinds of compounds because of
the processing method employed, causing partial hydrolysis
of esters and glycosides (Blumenthal 2003).
Several bioactive compounds have been identified in P.
ginseng, including polysaccharides, polyenes, flavonoids,
volatile oils and ginsenosides (Hou 1977). Of these, the ginsenosides are perhaps the best characterized. Ginsenosides
or saponins contain four ring hydrophobic steroid-like
structures with attached sugars which may be a glucose,
maltose, fructose, galactose, pentose, or methylpentose (Liu
and Xiao 1992; Coates 2005). It is in the variation, number,
and position of the sugar group that account for each ginsenosides’ unique physiological effect on the body. To date,
38 ginsenosides have been isolated from P. ginseng, far
exceeding the number of ginsenosides found in any other
species (Choi 2008). Ginsenosides have been divided into
groups based on their structure. Most ginsenosides belong
to one of two main groups, protopanaxadiols (PPD) and
protopanaxatriols (PPT), which differ at the C6 position
(Leung and Wong 2010). There are also rare ginsenosides,
such as oleanane (Leung and Wong 2010). Ginsenoside
content varies depending upon the age of the plant and season at the time of harvest, the part of the plant used, and
how the plant material is processed (preserved and extracted) (Liberti and Der Marderosian 1978). Interestingly, the
ratio of ginsenosides can determine physiological effect (Jin
et al. 1999).
Due to the complex chemical composition of ginseng,
many different physiological effects have been noted to be
consistent with its use as a panacea. The literature is vast,
thus the reader is referred to several recent reviews summarizing ginseng’s immune system modulatory, anti-cancer
and cytotoxic, neuroprotective, memory and learning stimulatory, antihyperglycemic, aphrodisiac and cardiovascular
effects (Radad et al. 2006; Choi 2008; Christensen 2009; Jia
et al. 2009; Lee et al. 2009b). This chapter focuses on the
antimicrobial effects of P. ginseng extracts and components.
Three mechanisms of microbial inhibition have been attributed to P. ginseng: inhibition of infection via immune system modulation, direct antibacterial activity, or inhibition of
virulence factor production.
To better understand how P. ginseng affects the immune
system response to microbial infection, a brief summary of
the immune system focusing on aspects affected by ginseng
is warranted. The initial response is detection of the pathogen by the innate immune system. This occurs by recognition of pathogen-associated molecular patterns (PAMPs) by
its cognate Toll-like receptor (TLR) (Janeway 1989; Medzhitov et al. 1997; Uematsu and Akira 2008). PAMP binding to TLRs activates a signaling pathway that requires the
adapter protein, myeloid differentiation primary response
gene 88 (MyD88) (Lord et al. 1990; Medzhitov et al. 1998).
Depending upon which TLR is conducting the signal, different cytokines are secreted which in turn activate the
adaptive immune response (Medzhitov and Janeway 1999).
This includes differentiation of CD4 cells into various T
helper (Th) cell lineages including Th1, Th2, and Th17 (reviewed in Zhu et al. 2010). The Th1 response is required to
clear intracellular pathogens, the Th2 response is important
for extracellular pathogens, and the Th17 response targets
Gram negative bacteria, fungi and select protozoa (reviewed in Fietta and Delsante 2009)). In a Th1 response,
secretion of IFN-, interleukin-2 (IL-2), and tumor necrosis
factor alpha (TNF-) (Mosmann et al. 1986; Killar et al.
1987) leads to macrophage activation and cellular immunity
(Meltzer et al. 1982). Interleukin 12 (IL-12) is important for
the Th1 response because it induces IFN- and TNF production, natural killer cell and T-cell proliferation and CD-4
to Th1 cell differentiation (Trinchieri et al. 1992). A Th2
response results in humoral immunity through secretion of
interleukin 4 (IL-4), interleukin 5 (IL-5), and interleukin 13
(IL-13) (Mosmann et al. 1986; Killar et al. 1987) which in
turn suppress macrophage activation and stimulate IgE production, as well as eosinophil and mast cell activation
(reviewed in Deo et al. 2010). If the pathogen enters macro-

Panax ginseng
Ginseng has a long history of medicinal use, especially in
China, Japan and Korea, and is highly valued. Used for
rejuvenation of the body, it is considered an adaptogen, able
to bolster the body’s immune system during times of stress
(Brekhman and Dardymov 1969). It is also believed to improve stamina and concentration (Petkov et al. 1994). In
addition, it is believed to maintain homeostatic balance of
the body. This is probably due to a wide range of chemicals
found in the plant.
The Latin name for Asian ginseng is P. ginseng. The
term “ginseng” is derived from the Chinese phonetic pronunciation of ginseng, which is rén shn, or “the image of
man,” because of the roots’ anthropomorphic resemblance
to the human body. Ginseng belongs to the genus Panax,
derived from the Greek word for cure all, “panacea,”
because it was believed to be a universal remedy. There are
about 11 species of the genus Panax. All are characterized
by the presence of ginsenosides. Besides P. ginseng, American ginseng (Panax quinquefolius) is also used in herbal
medicine and extensively researched. In addition, Tienchi or
Sanchi (Panax notoginseng), Japanese ginseng (Panax
japonicus), and Vietnamese ginseng (Panax vietnamensis)
are also widely grown and used as folk remedies (Yun
2001). While some compounds are shared by many of the
Panax species, some are only found in one. These distinctions are useful in determining purity of ginseng preparations. For example, the ginsenoside Rf, is found in P. ginseng but not in P. quinquefolius (Li et al. 2000).
P. ginseng is typically found in the cooler regions of the
Northern Hemisphere. Often reaching a height of six to 18
inches, the slow growing perennial plant has one to three
umbels of 15 to 30 flowers and bears a round, small-sized,
red berry (Fleming 1998). Roots are often harvested at four
to six years of age. Roots are yellowish white and contain a
primary root divided into rootlets and root hairs. Depending
on the time of harvest and processing of the root, it can be
called either white or red ginseng (Yun 2001). White ginseng is when the peeled root has been dried in the sun and
retains a white color. Red ginseng refers to the steaming and
boiling of the root resulting in the titular color. Both types
17
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phages, a Th2 response would cause extensive tissue
damage without affecting the pathogen, while the inflammation caused by the Th1 response would not be as damaging and would likely slow disease progression due to increased pathogen clearance. P. aeruginosa infection promotes a Th2 response, in part by production of 3OC12-HSL
(Telford et al. 1998).
P. ginseng has long been known to have immunomodulatory activities (reviewed in Spelman et al. 2006). Modulation of the immune system by P. ginseng also enhances
bacterial clearance (Song et al. 1997a). Crude aqueous extracts administered subcutaneously to a P. aeruginosa infected chronic pneumonia rat model system resulted in less
severe lung pathology and a reduction in numbers of mast
cells in lung foci, total immunoglobulin (IgG) levels and
bacterial load with respect to infected animals treated with
cortisone or saline instead of ginseng (Song et al. 1997a).
The polymorphonuclear cell oxidative burst response and
serum IgG2 levels were increased compared to the untreated or uninfected controls (Song et al. 1998). Interestingly, similar results were also observed in athymic rats
(Song et al. 1997b). Together, these data suggest that ginseng activates innate immunity, enhances the Th1 response
and down-regulates the Th2 response (Song et al. 1997a,
1997b, 1998). These studies did not measure cytokines.
Cytokines were measured in studies using a commercial
preparation of ginseng, Gerimax ginseng, on the same P.
aeruginosa rat model infection system (Song et al. 2002).
Daily ginseng treatment resulted in decreased serum IgM
and lung IL-4 levels seven days post infection. By day 21,
lung IgA, IFN-, IL-4 and TNF- and serum IgG2a responses were increased and lung pathology and P. aeruginosa
colony forming units were reduced (Song et al. 2002). This
is suggestive that ginseng promotes a shift from a Th2 to
Th1 response. An in vitro assay showed that addition of
Gerimax ginseng aqueous extracts in the presence of LPS
and IFN- to peripheral blood mononuclear cells increased
IL-12 production by at least 5% compared to control, further suggesting that ginseng can stimulate the Th1 response
(Larsen et al. 2004). Experiments with P. ginseng using a
mouse chronic P. aeruginosa infection model also corroborate this effect, IFN- and TNF- levels as well as IFN/IL-4 ratio were higher and IL-4 levels were lower in the
ginseng-treated animals relative to the control group (Song
et al. 2003). As before, there was a milder lung pathology
and increased bacterial clearance (Song et al. 2003).
Although it is possible that the aqueous P. ginseng
extract affected P. aeruginosa clearance only by modulating
the immune system, recent studies have shown that it
directly inhibits P. aeruginosa QS (Song et al. 2010). Addition of ginseng extract to PAO1 cultures resulted in decreased 3OC12-HSL and C4-HSL production, LasA and
LasB activity, without affecting growth. Since 3OC12-HSL
stimulates the Th2 response, and ginseng promotes the Th1
response over that of Th2, it is possible that this is accomplished at least in part through QS inhibition. In agreement with this, aqueous P. ginseng extracts reduced biofilm
formation and disrupted pre-formed biofilms in P. aeruginosa (Wu et al. 2011). Twitching and swimming motility
were enhanced while swarming was also reduced (Wu et al.
2011). Biofilm formation and swarming are both QS-dependent (Davies et al. 1998, Kohler et al. 2000). Recently, an
acetone:water extract of P. notoginseng flowers were shown
to have antibacterial and anti-QS activity against C. violaceum and inhibit swarming in P. aeruginosa (Koh and
Tham 2011).
Thus, ginseng seems to offer promise as an antiPseudomonas therapeutic agent, however, more investigation is needed. As previously stated, overproduction of alginate and conversion to a mucoid phenotype by P. aeruginosa leads to poor patient prognosis. Addition of aqueous
ginseng extract to a well-characterized mucoid variant of
PAO1 stimulated alginate production, yet reduced biofilm
formation in vitro (Song et al. 2010; Wu et al. 2011). This
may be explained by the observation that alginate produc-

tion promotes formation of three-dimensional biofilms,
while reducing biofilm formation in a solid-surface assay
(Hay et al. 2009). Thus, additional studies must be performed to determine the suitability and conditions of ginseng use in treatment of acute and chronic P. aeruginosa
infections. Also, since these observations were made using
a crude extract, it is possible that different compounds are
responsible for the different activities. Purification, characterization and identification of the active compounds may
facilitate the development of therapeutics with different
modes of action.
Purified components of P. ginseng also modulate the
immune system to facilitate bacterial clearance (Lim et al.
2002; Ahn et al. 2006a). Ginsan is an acidic polysaccharide
present in the ethanol insoluble aqueous fraction that consists of (16) glucopyranoside and (26) fructofuranoside (Lee et al. 1997; Ahn et al. 2006a, 2006b). Ginsan does
not have a direct antibacterial effect on S. aureus in vitro
(Lim et al. 2002; Ahn et al. 2006b), but has an anti-septicaemic effect in mice infected with S. aureus (Lim et al.
2002). Pretreatment of mice with ginsan protected the animals from death due to S. aureus infection (Lim et al. 2002;
Ahn et al. 2006a). Increased bacterial clearance was observed that may be due to a reduced early acute inflammatory response and enhanced macrophage activation (Lim
et al. 2002; Ahn et al. 2006a). Ginsan did increase the in
vitro phagocytic activity of macrophages (Ahn et al. 2006b).
To further analyze if ginsan was acting through macrophages in vivo, mice were treated with the anti-cancer drug
etoposide, which depletes macrophages (Ahn et al. 2006b).
Etoposide treatment and ginsan lowered bacterial levels and
increased survival rates compared to mice treated with just
etoposide, suggesting that the anti-bacterial activity was not
through ginsan acting on macrophages (Ahn et al. 2006b),
however, it is possible that the etoposide did not completely
deplete the macrophages.
Ginsan may act by down-regulating inflammatory cytokines. In sepsis, Toll-like receptor and MyD88 are also key
players in the inflammatory response as they detect PAMPs
and transduce the signal to induce expression of relevant
genes and certain cytokines (Peck-Palmer et al. 2008). In
vivo, pretreatment of mice with ginsan prior to infection
with S. aureus, resulted in decreased levels of IL-1, IL-6,
TNF-, IFN-, IL-12 and IL-18 (Ahn et al. 2006b), which
are usually elevated in sepsis. Ginsan treatment decreased
levels of Toll-like receptor and MyD88 in mouse peritoneal
macrophages treated with heat-killed S. aureus in vitro
(Ahn et al. 2006b). By activating macrophages and downregulating inflammatory cytokines, ginsan is able to impart
a protective effect on mice. Ginsan treatment combined
with vancomycin administration enhances survival in this
mouse septic model system (Lim et al. 2002).
Besides being a biological response modifier, acidic
polysaccharides purified from P. ginseng display anti-adhesive activities (Belogortseva et al. 2000; Lee et al. 2004a,
2004b, 2006, 2009a). The structures of these are not as well
characterized as ginsan, however, these polysaccharides are
pectin-like and are rich in uronic acid, with the majority
being galacturonic acid (Lee et al. 2009a). These effectively
inhibit adhesion of the gut pathogen, Helicobacter pylori,
the oral pathogens Porphytomonas gingivalis and Actinobacillus actinomycetemcomitans, and the skin pathogens
Propionibacterium acnes and S. aureus (Lee et al. 2004b,
2006, 2009a). Interestingly, these polysaccharides did not
affect adhesion of the commensal bacteria Staphylococcus
epidermidis, E. coli, Lactobacillus acidophilus and Bifidobacterium bifidum (Lee et al. 2006, 2009a). The polysaccharides did not affect growth of either the mammalian cells
or the bacteria (Lee et al. 2006, 2009a). These properties of
only targeting pathogenic bacteria without harming the
natural flora or the host cells make these compounds potential therapeutics.
Polyacetylenes have also been isolated from P. ginseng
(Fujimoto and Satoh 1988; Matsunaga et al. 1989; Fujimoto
et al. 1990). One of these, panaxytriol, inhibits growth of H.
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Table 2 Summary of anti-microbial effects of Panax ginseng.
Panax ginseng
Target organism
component
Aqueous extract
P. aeruginosa

Ginsan

S. aureus

Uronic acid-rich
polysaccharides
Panaxytriol
Ginsenosides

H. pylori, P. gingivalis, S. aureus, P.
acnes, A. acitinomycetemcomitans
H. pylori
S. aureus, S. epidermis, S.
typhimuriaum, V. vulnificus

Effect

Reference

Immunoclearance
Shift to Th1 response
QS inhibition
Reduced biofilm formation
Reduced swarming, enhanced motility
Reduced acute inflammatory response, enhanced
macrophage activation, anti-septicaemic effect
Enhanced macrophage phagocytic in vitro activity
Adhesion inhibition

Song et al. 1997a
Song et al. 1997a, 1997b, 1998
Song et al. 2010
Wu et al. 2011
Wu et al. 2011
Lin et al. 2002, Ahn et al.
2006a
Ahn et al. 2006b
Lee et al. 2004b, 2006, 2009a

Growth inhibition
Growth inhibition

Bae et al. 2001
Sung and Lee 2008

CONCLUSION
In summary, ginseng contains immunomodulatory, antimicrobial and anti-QS compounds that may be useful in treatment of bacterial infections (Fig. 3, Table 2). While some
active compounds have been isolated and characterized,
limited studies have been performed and the main compounds responsible for the anti-Pseudomonas immune system modulation and anti-QS effect remain to be purified.
Once the bioactive compound(s) have been isolated they
can be characterized for their effects alone and in combination with other effective compounds and antibiotics in
vitro and in animal models. These studies will pave the way
for ginseng use as an anti-infective therapeutic.
ACKNOWLEDGEMENTS
Fig. 3 Summary of Panax ginseng activities affecting microbial
growth and pathogenesis.

This work was supported by grants to KM from the National
Institutes of Health, National Center for Alternative and Complementary Medicine (1-R15-AT002626) and the Cystic Fibrosis
Foundation (MATHEE0110). The authors would like to thank current and past members of the Mathee laboratory for their insightful
discussions and would like to especially acknowledge Diansy
Zincke for her thoughtful comments.

pylori (Bae et al. 2001). Panaxytriol is also a cell cycle
inhibitor, arresting a mouse lymphoma cell line, P388D1 at
G2/M (Kim et al. 2002). To date, there is limited literature
on the anti-bacterial activity of P. ginseng derived polyacetylenes, although polyacetylenes isolated from other
sources have been demonstrated to affect microbial growth
(Lechner et al. 2004; Schinkovitz et al. 2008).
Ginsenosides have also been identified as having antibacterial and immunomodulatory activities. A ginsenoside
fraction purified from P. ginseng containing Rb1, Rb2, Rc,
Rd, Re, Rf, Rg1, Rg2, Rg3, Rh2 inhibited growth at a minimum inhibitory concentration (MIC) of 100 μg/ml of S.
aureus, S. epidermidis, Salmonella typhimurium, and Vibrio
vulnificus (Sung and Lee 2008). The ginsenosides were not
as effective as the positive controls, nisin (MIC against the
Gram positive bacteria, 40 μg/ml) and propionic acid (MIC
against Gram negative bacteria, 50 μg/ml). The ginsenosides exhibited a synergistic effect with kanamycin and
cefotaxime against MRSA (Sung and Lee 2008). The exact
mechanism for this effect is unknown but since ginsenosides are amphipathic they may interact with the cell membrane and allow entry of the antibiotic into the cell. In
agreement with perturbation of the cell membrane by the
ginsenosides, addition of the ginsenosides to calcein-encapsulated large unilamellar vesicles resulted in a dose-dependent leakage of dye (Sung and Lee 2008). Mitogen-induced
lymphocyte proliferation was reduced by treatment with
Rb2, Re and Rg1, but not Rb1 (Cho et al. 2002). A caveat to
these results is that the ginsenosides used were purified
from P. ginseng and the fraction may contain other compounds, although the fractions shown to have immunomodulatory effects were >95% pure.
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